Statins reduce further deposition of lipid and in some cases with very high dose statin, some marginal reduction in atheroma may be seen.

In patients with substantial atheroma, one wants appreciable reversal and removal of lipid. Statins cannot do this

Initial studies with HDL infusions have shown promising results, but problems exist with immunogenicity .

Can HDL be rendered less immunogenic and is it a potential game changer in the world of cardiovascular disease and death?

Can we one day 'clean out' the atheroma from our arteries with this intervention?

More Fazleh Mahomed's questions See All
Similar questions and discussions